Staar Surgical price target lowered to $45 from $50 at Stifel

Stifel analyst Thomas Stephan lowered the firm’s price target on Staar Surgical to $45 from $50 and keeps a Hold rating on the shares. With top-line growth expectations reset, the low-end of the 15%-20% outlook represents “a fairly solid floor,” but the firm continues to “struggle with where more meaningful upside to numbers (and the multiple) exists from here,” the analyst tells investors following a review of the company’s Q2 10-Q report.